Symbol="ESPR"
AssetType="Common Stock"
Name="Esperion Therapeutics Inc"
Description="Esperion Therapeutics, Inc., a pharmaceutical company, develops and markets drugs for the treatment of patients with high low-density lipoprotein cholesterol in the United States and internationally. The company is headquartered in Ann Arbor, Michigan."
CIK="1434868"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="136386000"
EBITDA="-184688992"
PERatio="None"
PEGRatio="-4.78"
BookValue="-3.779"
DividendPerShare="0"
DividendYield="0"
EPS="-3.17"
RevenuePerShareTTM="1.144"
ProfitMargin="-2.947"
OperatingMarginTTM="-2.286"
ReturnOnAssetsTTM="-0.389"
ReturnOnEquityTTM="-2.608"
RevenueTTM="80968000"
GrossProfitTTM="-70419000"
DilutedEPSTTM="-3.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.292"
AnalystTargetPrice="10.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="5.98"
PriceToBookRatio="98.42"
EVToRevenue="6.93"
EVToEBITDA="-2.675"
Beta="0.135"
num_52WeekHigh="8.87"
num_52WeekLow="1.12"
num_50DayMovingAverage="1.456"
num_200DayMovingAverage="4.494"
SharesOutstanding="94713000"
DividendDate="None"
ExDividendDate="None"
symbol="ESPR"
open="1.44"
high="1.51"
low="1.42"
price="1.49"
volume="1376102.00"
latest_trading_day="2023-07-17"
previous_close="1.44"
change="0.05"
change_percent="3.4722%"
aroon_positive_momentum_days="15"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="3638051"
Change_recent_avg="-0.01"
Delta_recent_avg="0.19"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.75"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="144"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0032.jpeg"
image_negative_thumbnail_id_2="109"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_neutral_thumbnail_id_1="586"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="654"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_positive_thumbnail_id_2="706"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0002.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
